CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-05 | Miller Larry Lee Chief Operating Officer | Sale | −810 | $36.49 | $30K | 0 |
| 2017-09-05 | Miller Larry Lee Chief Operating Officer | Option exercise · Option to purchase Common Stock | −5,047 | 167,453 | ||
| 2017-09-05 | Johnson Richard G Chief Financial Officer | Option exercise | +4,240 | $11.83 | $50K | 4,240 |
| 2017-09-05 | Johnson Richard G Chief Financial Officer | Sale | −4,240 | $35.56 | $151K | 0 |
| 2017-09-05 | Johnson Richard G Chief Financial Officer | Option exercise | +764 | $11.83 | $9K | 764 |
| 2017-09-05 | Johnson Richard G Chief Financial Officer | Sale | −764 | $36.54 | $28K | 0 |
| 2017-09-05 | Johnson Richard G Chief Financial Officer | Option exercise · Option to purchase Common Stock | −5,004 | 61,296 | ||
| 2017-08-21 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +800 | $11.83 | $9K | 800 |
| 2017-08-21 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −800 | $40.02 | $32K | 0 |
| 2017-08-21 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −800 | 27,123 | ||
| 2017-08-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +4,176 | $11.83 | $49K | 4,176 |
| 2017-08-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −4,176 | $40.01 | $167K | 0 |
| 2017-08-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −4,176 | 27,923 | ||
| 2017-08-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +5,938 | $11.83 | $70K | 5,938 |
| 2017-08-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −5,938 | $40.04 | $238K | 0 |
| 2017-08-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −5,938 | 32,099 | ||
| 2017-08-15 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +1,443 | $11.83 | $17K | 1,443 |
| 2017-08-15 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −1,443 | $40.05 | $58K | 0 |
| 2017-08-15 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −1,443 | 38,037 | ||
| 2017-08-14 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +300 | $11.83 | $4K | 300 |
Page 27 of 41 · 803 trades